Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.

Schmidt MA, Crane B, Mullooly JP, Naleway AL.

Vaccine. 2010 Nov 16;28(49):7713-5. doi: 10.1016/j.vaccine.2010.09.043. Epub 2010 Sep 25.

PMID:
20875495
[PubMed - indexed for MEDLINE]
2.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
[PubMed - indexed for MEDLINE]
3.

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.

Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112.

PMID:
21810637
[PubMed - indexed for MEDLINE]
4.

Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.

Neuzil KM, Jackson LA, Nelson J, Klimov A, Cox N, Bridges CB, Dunn J, DeStefano F, Shay D.

J Infect Dis. 2006 Oct 15;194(8):1032-9. Epub 2006 Sep 11.

PMID:
16991077
[PubMed - indexed for MEDLINE]
Free Article
5.

Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study.

Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD; GRC28 Study Team.

Pediatr Infect Dis J. 2010 Feb;29(2):105-10. doi: 10.1097/INF.0b013e3181b84c34.

PMID:
19934787
[PubMed - indexed for MEDLINE]
6.

Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine.

Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM.

Vaccine. 2008 Jul 29;26(32):4057-61. doi: 10.1016/j.vaccine.2008.05.024. Epub 2008 Jun 2.

PMID:
18602726
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Trivalent inactivated influenza vaccine is not associated with sickle cell hospitalizations in adults from a large cohort.

Hambidge SJ, Ross C, McClure D, Glanz J; VSD team.

Vaccine. 2011 Oct 26;29(46):8179-81. doi: 10.1016/j.vaccine.2011.09.002. Epub 2011 Sep 17.

PMID:
21930176
[PubMed - indexed for MEDLINE]
8.

Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.

Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.

Pediatrics. 2007 Sep;120(3):e553-64. Epub 2007 Aug 13.

PMID:
17698577
[PubMed - indexed for MEDLINE]
Free Article
9.

Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010.

Greene SK, Rett M, Weintraub ES, Li L, Yin R, Amato AA, Ho DT, Sheikh SI, Fireman BH, Daley MF, Belongia EA, Jacobsen SJ, Baxter R, Lieu TA, Kulldorff M, Vellozzi C, Lee GM.

Am J Epidemiol. 2012 Jun 1;175(11):1100-9. doi: 10.1093/aje/kws195. Epub 2012 May 11.

PMID:
22582210
[PubMed - indexed for MEDLINE]
Free Article
10.

Maternal safety of trivalent inactivated influenza vaccine in pregnant women.

Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, Lee GM, Hambidge S, Shi W, Olsen A.

Obstet Gynecol. 2013 Mar;121(3):519-25. doi: 10.1097/AOG.0b013e3182831b83.

PMID:
23635613
[PubMed - indexed for MEDLINE]
11.

Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.

Leeb A, Carcione D, Richmond PC, Jacoby P, Effler PV.

Vaccine. 2011 Oct 19;29(45):7920-4. doi: 10.1016/j.vaccine.2011.08.073. Epub 2011 Aug 22.

PMID:
21864621
[PubMed - indexed for MEDLINE]
12.

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.

Fiore AE, Uyeki TM, Broder K, Finelli L, Euler GL, Singleton JA, Iskander JK, Wortley PM, Shay DK, Bresee JS, Cox NJ; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2010 Aug 6;59(RR-8):1-62. Erratum in: MMWR Recomm Rep. 2010 Aug 13;59(31):993. MMWR Recomm Rep. 2010 Sep 10;59(35):1147.

PMID:
20689501
[PubMed - indexed for MEDLINE]
Free Article
13.

Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.

Leroux-Roels I, Vets E, Freese R, Seiberling M, Weber F, Salamand C, Leroux-Roels G.

Vaccine. 2008 Dec 2;26(51):6614-9. doi: 10.1016/j.vaccine.2008.09.078. Erratum in: Vaccine. 2010 Nov 23;28(50):8033.

PMID:
18930093
[PubMed - indexed for MEDLINE]
14.

Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: a case-control study.

Joshi AY, Iyer VN, St Sauver JL, Jacobson RM, Boyce TG.

Vaccine. 2009 Jul 16;27(33):4457-61. doi: 10.1016/j.vaccine.2009.05.038. Epub 2009 May 31.

PMID:
19490957
[PubMed - indexed for MEDLINE]
15.

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents.

Lambert SB, Chuk LM, Nissen MD, Nolan TM, McVernon J, Booy R, Heron L, Richmond PC, Walls T, Marshall HS, Reynolds GJ, Hartel GF, Hu W, Lai MH.

Influenza Other Respir Viruses. 2013 Sep;7(5):676-85. doi: 10.1111/irv.12107. Epub 2013 Apr 2.

PMID:
23551933
[PubMed - indexed for MEDLINE]
16.

The use of inactivated influenza vaccine in children.

Wright PF.

Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. Review.

PMID:
17055371
[PubMed - indexed for MEDLINE]
17.

[Clinical trial on safety of inactivated split influenza virus vaccine, Anflu in 2007-2008].

Wang X, Liu Y, Zhao YW.

Zhongguo Yi Miao He Mian Yi. 2009 Oct;15(5):443-6. Chinese.

PMID:
20084973
[PubMed - indexed for MEDLINE]
18.

Effectiveness of trivalent inactivated influenza vaccine in influenza-related hospitalization in children: a case-control study.

Joshi AY, Iyer VN, Hartz MF, Patel AM, Li JT.

Allergy Asthma Proc. 2012 Mar-Apr;33(2):e23-7. doi: 10.2500/aap.2012.33.3513.

PMID:
22525386
[PubMed - indexed for MEDLINE]
19.

Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.

Ashkenazi S, Vertruyen A, Arístegui J, Esposito S, McKeith DD, Klemola T, Biolek J, Kühr J, Bujnowski T, Desgrandchamps D, Cheng SM, Skinner J, Gruber WC, Forrest BD; CAIV-T Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):870-9.

PMID:
17006279
[PubMed - indexed for MEDLINE]
20.

Serious adverse events following receipt of trivalent inactivated influenza vaccine in Korea, 2003-2010.

Choe YJ, Cho H, Kim SN, Bae GR, Lee JK.

Vaccine. 2011 Oct 13;29(44):7727-32. doi: 10.1016/j.vaccine.2011.07.129. Epub 2011 Aug 7.

PMID:
21827815
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk